Search Medical Condition
Please enter condition
Please choose location from dropdown

Xuzhou, China Clinical Trials

A listing of Xuzhou, China clinical trials actively recruiting patients volunteers.

Found (75) clinical trials

Study of Methylnaltrexone in Opioid-Induced Constipation Patients

Methylnaltrexone is a quaternary derivative of the pure opioid antagonists naltrexone. It is fairly lipid soluble and readily cross the blood-brain barrier. This property provides methylnaltrexone with the potential to block the undesired side-effects of opioid pain medications predominantly mediated by receptors located peripherally while sparing opioid effects mediated at …

Phase

6.14 miles

Learn More »

Prospective Multicenter Randomized Controlled Study to Evaluate the Effect of INTERCEED

This is a prospective, randomized controlled study. The study population will include 220 subjects scheduled to undergo laparoscopic radical resection of rectal carcinoma with preventive ileostomy (Phase 1 operation). During the Phase 1 operation, when the definite decision to create a temporary ostomy is made, patients will be randomized in …

Phase

6.14 miles

Learn More »

Association Study Postoperative Cognitive Dysfunction Associated With Inflammation Polymorphism

study 1.1 The study inclusion criteria: The study in January 2015 - June 2015 Xuzhou Medical College Hospital orthopedic ward in elderly patients, level of education for primary ((0 <schooling 6). Check all other indicators of the patients were in the normal range, no liver, kidney, lung, heart and other …

Phase N/A

6.14 miles

Learn More »

Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism

Thyroid hormone (TH) is a critical hormone responsible for growth, development, and metabolism. It maintains basal metabolic rate (BMR), improves adaptive thermogenesis, and thus modulates body weight by fine-tuning energy expenditure and intake. Hyperthyroidism, a condition with excess TH, presents a status of negative energy balance that is characterized by …

Phase N/A

6.14 miles

Learn More »

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

CD19 is an ideal target with great potential for treating B-cell-derived hematological malignancies. Although the complete remission rate is as high as 93% by using CD19-targeting CAR-T technology, approximately 60% patients will have recurrent disease. Among all the recurrent patients, two thirds is revealed to loss their CD19 expression on …

Phase

6.14 miles

Learn More »

Effect of Disconnecting Pulmonary Vagus Nerve Branch on Chronic Cough After Unilateral Thoracoscopic Lobectomy

After screened for the Inclusion criteria and the exclusion criteria,254patients undergoing unilateral thoracoscopic lobectomy are randomly assigned to two groups,disconnecting pulmonary vague nerve branches(D)and preserve pulmonary vague nerve branches(P).The surgeons find the vagus nerve pulmonary branch leading to the hilum and count the number of branches on all patients included.The …

Phase N/A

6.14 miles

Learn More »

OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)

This study is a prospective, randomized controlled clinical trial, which will adopt the central randomized method based on computer system. When a patient signs the informed consent form and meets the inclusion criteria of the trial, and there is no exclusion criteria for randomization, the researcher fills in the randomization …

Phase N/A

6.14 miles

Learn More »

A Randomized Non-inferiority Study of Low-dose and Standard-dose Ticagrelor After Intervention for Acute Coronary Syndrome

This study is to evaluate the safety and efficacy of 60mg ticagrelor plus 100mg Aspirin to prevent major adverse cardiovascular and cerebrovascular events in one years after drug-eluting stents implantation for Chinese ACS patients compared with 90mg ticagrelor plus 100mg Aspirin

Phase

6.74 miles

Learn More »

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

This is a global, Phase 3, randomized study of zanubrutinib versus ibrutinib in approximately 600 participants with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The primary efficacy endpoint is overall response rate determined by investigator assessment. Participants will be randomized in a 1:1 manner to either zanubrutinib or ibrutinib. …

Phase

7.58 miles

Learn More »

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled study of evolocumab in Chinese Subjects with hypercholesterolemia and mixed dyslipidemia. Subjects who have signed the informed consent form (ICF), will have fasting lipids measured and all inclusion and exclusion criteria assessed. Subjects should maintain their current diet and exercise regimen. …

Phase

7.58 miles

Learn More »